|Year : 2013 | Volume
| Issue : 33 | Page : 4-8
A validated high performance thin layer chromatography method for determination of yohimbine hydrochloride in pharmaceutical preparations
Jihan M Badr
Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
|Date of Submission||05-Jan-2012|
|Date of Decision||22-Feb-2012|
|Date of Web Publication||05-Mar-2013|
Jihan M Badr
Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia, Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Yohimbine is an indole alkaloid used as a promising therapy for erectile dysfunction. A number of methods were reported for the analysis of yohimbine in the bark or in pharmaceutical preparations. Materials and Method: In the present work, a simple and sensitive high performance thin layer chromatographic method is developed for determination of yohimbine (occurring as yohimbine hydrochloride) in pharmaceutical preparations and validated according to International Conference of Harmonization (ICH) guidelines. The method employed thin layer chromatography aluminum sheets precoated with silica gel as the stationary phase and the mobile phase consisted of chloroform:methanol:ammonia (97:3:0.2), which gave compact bands of yohimbine hydrochloride. Results: Linear regression data for the calibration curves of standard yohimbine hydrochloride showed a good linear relationship over a concentration range of 80-1000 ng/spot with respect to the area and correlation coefficient (R 2 ) was 0.9965. The method was evaluated regarding accuracy, precision, selectivity, and robustness. Limits of detection and quantitation were recorded as 5 and 40 ng/spot, respectively. The proposed method efficiently separated yohimbine hydrochloride from other components even in complex mixture containing powdered plants. The amount of yohimbine hydrochloride ranged from 2.3 to 5.2 mg/tablet or capsule in preparations containing the pure alkaloid, while it varied from zero (0) to 1.5-1.8 mg/capsule in dietary supplements containing powdered yohimbe bark. Conclusion: We concluded that this method employing high performance thin layer chromatography (HPTLC) in quantitative determination of yohimbine hydrochloride in pharmaceutical preparations is efficient, simple, accurate, and validated.
Keywords: Accuracy, dietary supplements, high performance thin layer chromatography, precision, selectivity, yohimbine
|How to cite this article:|
Badr JM. A validated high performance thin layer chromatography method for determination of yohimbine hydrochloride in pharmaceutical preparations. Phcog Mag 2013;9:4-8
|How to cite this URL:|
Badr JM. A validated high performance thin layer chromatography method for determination of yohimbine hydrochloride in pharmaceutical preparations. Phcog Mag [serial online] 2013 [cited 2020 Aug 7];9:4-8. Available from: http://www.phcog.com/text.asp?2013/9/33/4/108124
| Introduction|| |
Yohimbine is an indole alkaloid obtained naturally from Pausinystalia yohimbe. It occurs also in Rauwlfia serpentina along with other active alkaloids. Many research articles have focused on the efficacy of yohimbine as a promising therapy for erectile dysfunction. ,,, Yohimbine acts as a competitive antagonist selective for α-2 adrenergic receptor.  It should be administered with caution to patients with high blood pressure.  In addition, a slight anxiogenic action and increased frequency of urination could be noticed at relatively high doses.  Yohimbine is available in a number of pharmaceutical preparations including tablets and capsules; moreover, the powdered yohimbe bark is included in some dietary supplements. Since dietary supplements are considered as over the counter products; hence, these could be administered without doctor's prescription. For that reason, it is important to design a simple and reproducible method to estimate yohimbine in pharmaceutical preparations including these dietary supplements. A number of methods were reported for the analysis of yohimbine in the bark or in pharmaceutical preparations. These included ultraviolet (UV) spectrophotometry,  high performance liquid chromatography (HPLC), ,, gas chromatography,  nonaqueous capillary electrophoresis,  phosphorimetry,  and colorimetry.  In the present work, yohimbine is quantitatively determined in five different pharmaceutical preparations including dietary supplements using high performance thin layer chromatography (HPTLC). On reviewing the literature, thin layer chromatography was previously used in qualitative detection and separation of a mixture of alkaloids including yohimbine from different species belonging to family Apocynaceae. , Accordingly, HPTLC is used and validated for the first time in the present work for quantitative estimation of yohimbine in pharmaceutical preparations.
| Materials and Methods|| |
A Camag (Wilmington, USA) Linomat IV sample applicator was used to dispense the aliquots of the standard stock solution and the prepared samples. The plates were saturated in a twin trough chamber; slit dimension settings of length 6 and width 0.1 mm, monochromator band width 20 nm and scanning rate of 10 mm/s. Zones were quantified by using Camag TLC Scanner III densitometer (Wilmington, USA) controlled by CATS version 4 × software in the absorption mode using a deuterium source and a filter with wavelength of 280 nm.
Chemicals and pharmaceutical products
Standard yohimbine hydrochloride alkaloid was purchased from Sigma (Sigma-Aldrich, Germany), and certified to contain 99%. Solvents for extraction and development and precoated silica gel F 254 , 0.25 mm were obtained from Merck Company (Darmstadt, Germany). The pharmaceutical preparations (tablets and capsules) were purchased from local markets of Egypt and Kingdom of Saudi Arabia.
The standard stock solution was prepared by weighing 100 mg of the authentic sample of yohimbine hydrochloride then quantitatively transferred to 100 mL volumetric flask and volume was adjusted with methanol, kept in the refrigerator and tightly closed. One milliliter of the stock solution was withdrawn and accurately transferred to 10 mL volumetric flask and volume was made up with methanol (stock solution A). From stock solution A, 1 mL was accurately withdrawn and transferred to 10 mL volumetric flask and volume was adjusted with methanol to give stock solution B. The calibration curve was constructed according to the requirements of the International Conference of Harmonization (ICH) guidelines.
Five different products were used for this study. The products were selected so that they vary in composition and form to ensure validation of the method under different conditions. Two products (samples 1 and 2) were selected as tablets and capsules, respectively, containing mainly yohimbine hydrochloride together with lactose and sucrose (in sample 1) and vitamin E, nicotinic acid and caffeine (in sample 2). Three dietary supplements as capsules were chosen (samples 3, 4, and 5), each contains yohimbe bark powder together with royal jelly, ginseng, and bee pollen (in samples 3 and 4) and sample 5 contains royal jelly, ginseng, wheat germ oil, and garlic in addition to yohimbe bark powder. For extraction, 20 tablets or capsules were used from each product. The tablets (from sample 1) were finely ground by a mortar then sonnicated with methanol for 15 min, quantitatively transferred after filtration into 100 mL volumetric flash and volume was made up with methanol. The contents of 20 capsules from sample 2 were extracted by sonnication with methanol and treated as sample 1. The contents of the same number of capsules from samples 3 to 5 (containing yohimbe bark powder) were extracted by sonnication with acidulated methanol (prepared in a ratio of methanol:concentrated HCl (100:0.1 v/v)), then treated similarly as samples 1 and 2.
Calibration curve was constructed according to requirement of ICH guidelines. Each concentration was applied to a plate (20 × 10 cm) in triplicates of 6 mm band length with a distance of 4 mm between each two bands. The distance from the plate side edge was 10 mm and from the bottom of the plate was also 10 mm. The application rate was 15 μL/s, the bands were developed using chloroform:methanol:ammonia (97:3:0.2) after saturation for 20 min. The development time was 15 min, the plates were air dried for 10 min showing Rf = 0.58 ± 0.01. Standard zones were quantified by linear densitometric scanning using Camag TLC scanner in the absorbance mode at λ 280 nm, the wavelength corresponding to the maximum sensitivity. Deuterium lamp was utilized as a source of radiation. Evaluation was done using linear regression analysis via peak areas. [Figure 1] illustrates the densitogram recorded for a 300 ng/spot of standard yohimbine hydrochloride at λ 280 nm.
|Figure 1: HPTLC scan densitogram showing the injection of 300 ng/ spot of standard yohimbine hydrochloride [Y] scanned at λ 280 nm using chloroform: methanol: ammonia (97: 3: 0.2)|
Click here to view
After preparation of the five samples as previously described, 6 μL of each sample and the standard solution were spotted in triplicates on a plate, developed under the same conditions as described for the standard yohimbine hydrochloride. After development and drying of the plates, the analyte was found to be completely separated from other components so the linear and compact zones were scanned at λ 280 nm and peak areas for yohimbine hydrochloride were recorded. [Figure 2] illustrates the densitograms for two representative samples 2 and 4.
|Figure 2: HPTLC scan densitograms showing the injection of 6 μL of two representative samples [2 (a) and 4 (b)] scanned at λ 280 nm using chloroform: methanol: ammonia (97: 3: 0.2)|
Click here to view
| Results and Discussion|| |
The linearity of the HPTLC method was evaluated by analyzing a series of different concentrations of the standard yohimbine hydrochloride where each concentration was applied triplicate. Linear regression data for the calibration curves of standard yohimbine hydrochloride showed a good linear relationship over the concentration range of 80-1000 ng/spot with respect to the area. The correlation coefficient (R 2 ) was 0.9965 and linear regression equation was found to be: y = 22292 x + 7008.5, where y is the spot area and x is the concentration of the analyte.
Selective baseline separation was obtained between yohimbine hydrochloride and other components of the matrix in the samples 1 and 2. Moreover, good separation was noticed between yohimbine hydrochloride and the components of the complex mixtures in case of the dietary supplements (samples 3-5). The scan densitograms obtained from two different representative samples are presented in [Figure 2].
The system precision was assessed by determination of six different concentrations of yohimbine hydrochloride each applied triplicate.
Method precision (repeatability)
Repeated analysis of a homogenous sample (sample 2) applied in triplicate using the same procedure was also performed and the low value of relative standard deviation (RSD)% (1.93) indicated precision of the method [Table 1].
|Table 1: Validation parameters of the HPTLC method for estimation of yohimbine hydrochloride|
Click here to view
Accuracy of the method was ascertained by spiking of a preanalyzed sample (sample 2) with known amount of standard yohimbine hydrochloride solution and then analyzing by the same method. Analysis was performed in triplicates and the average percentage recovery at each concentration level was evaluated. The results are illustrated in [Table 2].
|Table 2: Recovery of yohimbine hydrochloride in sample 2 using the proposed method|
Click here to view
Limits of detection and quantitation
Limit of detection and limit of quantitation were validated based on signal to noise ratio where the minimum concentration at which the standard yohimbine hydrochloride solution can be reliably detected was recorded as 5 ng/spot (S/N = 3 of diluted standard) and minimum concentration at which the analyte can be reliably quantified (S/N = 10 of diluted standard) was found to be 40 ng/spot.
Robustness of the method was studied by carrying out the measurements under different conditions as slight changes in the composition of the developing mixture, changing the amount of developing mixture, time from spotting to chromatography and time from chromatography to scanning. Standard yohimbine hydrochloride solution was applied on plate in triplicates; the results are illustrated in [Table 3].
|Table 3: Robustness testing data of the HPTLC method for determination of yohimbine Hydrochloride|
Click here to view
Five products were analyzed by the proposed method [Table 4]. Samples 1 and 2 contained an amount of pure yohimbine hydrochloride equals 2.3 ± 1.7 and 5.2 ± 1.6 mg/tablet or capsule, respectively. The amount of yohimbine hydrochloride in the dietary supplements (samples 3-5) varied from 1.5 ± 1.1 in sample 3 to 1.8 ± 1.9 in sample 4 while it was not detected in sample 5. This variation could be attributed to the age of the plant at which the bark was collected.  At the contrary of sample 5, which was devoid of the analyte; samples 3 and 4 contained slightly higher amount than expected as yohimbe bark is reported to contain 0.8-2.24% of yohimbine alkaloid. This may be due to the variation in age of the plant as previously mentioned or due to addition of trace amounts of pure yohimbine hydrochloride on the content of the dietary supplements.
|Table 4: Amount of yohimbine hydrochloride determined in mg/tablet or capsule in the examined preparations compared with the concentrations illustrated on the product|
Click here to view
| Conclusions|| |
In order to ensure the quality of dietary supplements, these products should be subjected to analysis of the active constituents especially in case of containing active principles that may cause severe side effects when abused. A recent study was conducted and proved that a substantial increase in the prevalence of adverse side effects associated with yohimbine herbal products.  Moreover, it is known that the toxicity of yohimbine could be potentiated upon coadministration of a number of drugs including antidepressants  and drugs that interfere with tissue binding of noradrenaline as imipramine.  Since the proposed HPTLC method used for analysis was found to be specific, reproducible, accurate, simple, rapid, and separated yohimbine from other constituents, it could be proposed for routine quality control process of herbal supplements containing yohimbine.
| References|| |
|1.||Tanweer MS, Fatima A, Rahimnajiad MK. Yohimbine can be the new promising therapy for erectile dysfunction in type 2 diabetics. J Pak Med Assoc 2010;60:980. |
|2.||Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res 2002;14:25-31. |
|3.||Morales A. Yohimbine in erectile dysfunction: The facts. Int J Impot Res 2000;12:70-4. |
|4.||Kunelius P, Häkkinen J, Lukkarinen O. Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study. Urology 1997;49:441-4. |
|5.||Murburg MM, Villacres EC, Ko GN, Veith RC. Effects of yohimbine on human sympathetic nervous system function. J Clin Endocrinol Metab 1991;73:861-5. |
|6.||Grossman E, Rosenthal T, Peleg E, Holme C, Goldstein DS. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol 1993;22:22-6. |
|7.||Tama WS, Worcel M, Wyllie M. Yohimbine: A clinical review. Pharmacol Ther 2001;91:215-43. |
|8.||Singh D, Srivastava B, Sahu A. Spectrophotometric determination of Rauwolfia alkaloids: Estimation of reserpine in pharmaceuticals. Anal Sci 2004;20:571-3. |
|9.||Zanolari B, Ndjoko K, Ioset JR, Marston A, Hostettmann K. Qualitative and quantitative determination of yohimbine in authentic yohimbe bark and in commercial aphrodisiacs by HPLC-UV-API/ MS methods. Phytochem Anal 2003;14:193-201. |
|10.||Zhang Y, Huang Z, Ding L, Yan H, Wang M, Zhu S. Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry. J Sep Sci 2010;33:2109-14. |
|11.||Chib R, Ishii Y. Simultaneous determination of yohimbine hydrochloride, strychnine nitrate and methyltestosterone by ion-pair high-performance liquid chromatography. J Chromatogr A 1991;588:344-7. |
|12.||Betz JM, White KD, Der Marderosian AH. Gas chromatographic determination of yohimbine in commercial yohimbe products. J AOAC Int 1995;78:1189-94. |
|13.||Chen Q, Li P, Zhang Z, Li K, Liu J, Li Q. Analysis of yohimbine alkaloid from Pausinystalia yohimbe by non-aqueous capillary electrophoresis and gas chromatography-mass spectrometry. J Sep Sci 2008;31:2211-8. |
|14.||Arruda AF, Aucélio RQ. Room-temperature phosphorimetry for the selective determination of yohimbine in the presence of reserpine-like indolic alkaloids. Anal Sci 2002;18:831-4. |
|15.||Azhar I, Mazhar F, Manzar QN, Hussain I, Shamim S. Colorimetric determination of indolic drugs. Pak J Pharm Sci 2005;18:48-51. |
|16.||Klyushnichenko VE, Yakimov SA, Tuzova TP, Syagailo YV, Kuzovkina IN, Wulfson AN, et al. Determination of indole alkaloids from R. serpentina and R. vomitoria by high-performance liquid chromatography and high-performance thin-layer chromatography. J Chromatogr A 1995;704:357-62. |
|17.||Kumar A, Bhardwaj MK, Upadhyay AK, Tiwari A, Ohdar BD. Quantitative determination of yohimbine alkaloid in the different parts of the Rauvolfia tetraphylla. J Chem Pharm Res 2011;3: 907-10. |
|18.||Paris RR, Letouzey R. Alkaloid distribution in Pausinystalia Yohimbe. J Agric Trop Botan Appl 1960;256-8. |
|19.||Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: A retrospective review of the California poison control system reported cases. Ann Pharmacother 2010;44:1022-9. |
|20.||Lapin IP. Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs. Psychopharmacology (Berl) 1980;70:179-85. |
|21.||Quinton RM. The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice. Br J Pharmacol Chemother 1963;21:51-66. |
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||A comparative study of ICH validated novel spectrophotometric techniques for resolving completely overlapping spectra of quaternary mixtures
| ||Nouruddin W. Ali,Nada S. Abdelwahab,M. Abdelkawy,Aml A. Emam |
| ||Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2016; 154: 114 |
|[Pubmed] | [DOI]|
||Novel strategy for the determination of illegal adulterants in health foods and herbal medicines using high-performance liquid chromatography with high-resolution mass spectrometry
| ||Zhe Wang,Caisheng Wu,Gangli Wang,Qingsheng Zhang,Jinlan Zhang |
| ||Journal of Separation Science. 2015; 38(6): 925 |
|[Pubmed] | [DOI]|
||Simultaneous Determination of Reserpine, Rescinnamine, and Yohimbine in Human Plasma by Ultraperformance Liquid Chromatography Tandem Mass Spectrometry
| ||Muzaffar Iqbal,Aftab Alam,Tanveer A. Wani,Nasr Y. Khalil |
| ||Journal of Analytical Methods in Chemistry. 2013; 2013: 1 |
|[Pubmed] | [DOI]|